Safety aspects of gene therapy.

Suppr

超能文献

作者信息

Cornetta K

机构信息

Section of Hematology/Oncology, Indiana University, Indianapolis 46202.

出版信息

Br J Haematol. 1992 Apr;80(4):421-6. doi: 10.1111/j.1365-2141.1992.tb04552.x.

DOI:10.1111/j.1365-2141.1992.tb04552.x

PMID:1581226

Abstract

摘要

相似文献

Safety aspects of gene therapy.

Br J Haematol. 1992 Apr;80(4):421-6. doi: 10.1111/j.1365-2141.1992.tb04552.x.

Was it just stupid or are we poor educators?

Hum Gene Ther. 1994 Jul;5(7):791-2. doi: 10.1089/hum.1994.5.7-791.

Integration Site Analysis in Gene Therapy Patients: Expectations and Reality.

Hum Gene Ther. 2017 Dec;28(12):1122-1129. doi: 10.1089/hum.2017.183.

Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements?

Mol Ther. 2012 Feb;20(2):246-9. doi: 10.1038/mt.2011.288.

Safety issues related to retroviral-mediated gene transfer in humans.

Hum Gene Ther. 1991 Spring;2(1):5-14. doi: 10.1089/hum.1991.2.1-5.

Gene therapy for SCID--a complication after remarkable progress.

Lancet. 2002 Oct 19;360(9341):1185-6. doi: 10.1016/S0140-6736(02)11290-6.

Viral vector systems for gene therapy.

Cancer Gene Ther. 1994 Mar;1(1):51-64.

Sola dosis facit venenum. Leukemia in gene therapy trials: a question of vectors, inserts and dosage?

Leukemia. 2008 Oct;22(10):1849-52. doi: 10.1038/leu.2008.219. Epub 2008 Sep 4.

Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials.

Mol Ther. 2007 Apr;15(4):782-91. doi: 10.1038/sj.mt.6300083. Epub 2007 Feb 13.

Chance or necessity? Insertional mutagenesis in gene therapy and its consequences.

Mol Ther. 2004 Jan;9(1):5-13. doi: 10.1016/j.ymthe.2003.10.013.

引用本文的文献

Psi- vectors: murine leukemia virus-based self-inactivating and self-activating retroviral vectors.

J Virol. 1997 Aug;71(8):6218-24. doi: 10.1128/JVI.71.8.6218-6224.1997.

Pharmaceutical approach to somatic gene therapy.

Pharm Res. 1996 Nov;13(11):1595-614. doi: 10.1023/a:1016420102549.

Retroviral vectors. From laboratory tools to molecular medicine.

Mol Biotechnol. 1996 Apr;5(2):139-58. doi: 10.1007/BF02789062.

Human cancer and gene therapy.

Ann Hematol. 1994 Dec;69(6):273-9. doi: 10.1007/BF01696555.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Safety aspects of gene therapy.

Br J Haematol. 1992 Apr;80(4):421-6. doi: 10.1111/j.1365-2141.1992.tb04552.x.

Was it just stupid or are we poor educators?

Hum Gene Ther. 1994 Jul;5(7):791-2. doi: 10.1089/hum.1994.5.7-791.

Integration Site Analysis in Gene Therapy Patients: Expectations and Reality.

Hum Gene Ther. 2017 Dec;28(12):1122-1129. doi: 10.1089/hum.2017.183.

Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements?

Mol Ther. 2012 Feb;20(2):246-9. doi: 10.1038/mt.2011.288.

Safety issues related to retroviral-mediated gene transfer in humans.

Hum Gene Ther. 1991 Spring;2(1):5-14. doi: 10.1089/hum.1991.2.1-5.

Gene therapy for SCID--a complication after remarkable progress.

Lancet. 2002 Oct 19;360(9341):1185-6. doi: 10.1016/S0140-6736(02)11290-6.

Viral vector systems for gene therapy.

Cancer Gene Ther. 1994 Mar;1(1):51-64.

Sola dosis facit venenum. Leukemia in gene therapy trials: a question of vectors, inserts and dosage?

Leukemia. 2008 Oct;22(10):1849-52. doi: 10.1038/leu.2008.219. Epub 2008 Sep 4.

Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials.

Mol Ther. 2007 Apr;15(4):782-91. doi: 10.1038/sj.mt.6300083. Epub 2007 Feb 13.

Chance or necessity? Insertional mutagenesis in gene therapy and its consequences.

Mol Ther. 2004 Jan;9(1):5-13. doi: 10.1016/j.ymthe.2003.10.013.

引用本文的文献

Psi- vectors: murine leukemia virus-based self-inactivating and self-activating retroviral vectors.

J Virol. 1997 Aug;71(8):6218-24. doi: 10.1128/JVI.71.8.6218-6224.1997.

Pharmaceutical approach to somatic gene therapy.

Pharm Res. 1996 Nov;13(11):1595-614. doi: 10.1023/a:1016420102549.

Retroviral vectors. From laboratory tools to molecular medicine.

Mol Biotechnol. 1996 Apr;5(2):139-58. doi: 10.1007/BF02789062.

Human cancer and gene therapy.

Ann Hematol. 1994 Dec;69(6):273-9. doi: 10.1007/BF01696555.